ALDAGEN INC has a total of 13 patent applications. Its first patent ever was published in 2004. It filed its patents most often in EPO (European Patent Office), United States and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are FUJISAKI SHIGEMI, LYDAC NEUROSCIENCE LTD and SHROFF GEETA.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | United States | 3 | |
#3 | Canada | 2 | |
#4 | Japan | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Balber Andrew E | 10 |
#2 | Gentry Tracy | 6 |
#3 | Foster Sandra J | 6 |
#4 | Haley N Rebecca | 3 |
#5 | Kurtzberg Joanne | 3 |
Publication | Filing date | Title |
---|---|---|
WO2008060932A2 | Methods for improved engraftment following stem cell transplantation | |
AU2004316477A1 | Stem cell populations and methods of use |